American International Group, Inc. Intellia Therapeutics, Inc. Transaction History

American International Group, Inc.

  • $8.5 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$23.82 - $32.8 $7,741 - $10,659
325 Added 0.74%
44,180 $1.22 Million
Q4 2023

Feb 13, 2024
SELL
$23.16 - $32.34 $4,076 - $5,691
-176 Reduced 0.4%
43,855 $1.34 Million
Q3 2023

Nov 13, 2023
BUY
$31.62 - $45.78 $49,485 - $71,645
1,565 Added 3.69%
44,031 $1.39 Million
Q2 2023

Aug 04, 2023
BUY
$34.58 - $46.03 $84,963 - $113,095
2,457 Added 6.14%
42,466 $1.73 Million
Q1 2023

May 12, 2023
SELL
$33.3 - $44.82 $6,426 - $8,650
-193 Reduced 0.48%
40,009 $1.49 Million
Q4 2022

Feb 10, 2023
BUY
$33.21 - $62.69 $146,190 - $275,961
4,402 Added 12.3%
40,202 $1.4 Million
Q3 2022

Nov 14, 2022
BUY
$53.92 - $71.7 $27,229 - $36,208
505 Added 1.43%
35,800 $2 Million
Q2 2022

Aug 12, 2022
BUY
$38.49 - $76.21 $25,480 - $50,451
662 Added 1.91%
35,295 $1.83 Million
Q1 2022

May 13, 2022
SELL
$58.27 - $118.99 $142,062 - $290,097
-2,438 Reduced 6.58%
34,633 $2.52 Million
Q4 2021

Feb 11, 2022
SELL
$100.76 - $138.36 $63,478 - $87,166
-630 Reduced 1.67%
37,071 $4.38 Million
Q3 2021

Nov 12, 2021
BUY
$132.37 - $176.78 $252,164 - $336,765
1,905 Added 5.32%
37,701 $5.06 Million
Q2 2021

Aug 13, 2021
BUY
$60.88 - $161.91 $232,744 - $618,981
3,823 Added 11.96%
35,796 $5.8 Million
Q1 2021

May 07, 2021
BUY
$46.59 - $83.68 $132,548 - $238,069
2,845 Added 9.77%
31,973 $2.57 Million
Q4 2020

Feb 12, 2021
SELL
$18.83 - $63.53 $15,741 - $53,111
-836 Reduced 2.79%
29,128 $1.59 Million
Q3 2020

Nov 04, 2020
BUY
$17.47 - $24.93 $55,170 - $78,728
3,158 Added 11.78%
29,964 $596,000
Q2 2020

Aug 12, 2020
BUY
$11.14 - $22.87 $43,668 - $89,650
3,920 Added 17.13%
26,806 $563,000
Q1 2020

May 04, 2020
SELL
$9.44 - $15.58 $12,489 - $20,612
-1,323 Reduced 5.46%
22,886 $280,000
Q4 2019

Feb 05, 2020
SELL
$10.43 - $17.67 $2,117 - $3,587
-203 Reduced 0.83%
24,209 $355,000
Q3 2019

Nov 08, 2019
BUY
$13.07 - $18.51 $16,507 - $23,378
1,263 Added 5.46%
24,412 $326,000
Q2 2019

Aug 13, 2019
BUY
$13.88 - $18.41 $27,232 - $36,120
1,962 Added 9.26%
23,149 $379,000
Q1 2019

May 06, 2019
SELL
$12.79 - $17.62 $8,786 - $12,104
-687 Reduced 3.14%
21,187 $362,000
Q4 2018

Feb 13, 2019
SELL
$11.39 - $27.13 $1,913 - $4,557
-168 Reduced 0.76%
21,874 $299,000
Q3 2018

Nov 09, 2018
BUY
$25.78 - $32.6 $10,234 - $12,942
397 Added 1.83%
22,042 $631,000
Q2 2018

Aug 08, 2018
BUY
$20.02 - $30.79 $220,039 - $338,412
10,991 Added 103.16%
21,645 $592,000
Q1 2018

May 07, 2018
SELL
$19.43 - $34.95 $11,133 - $20,026
-573 Reduced 5.1%
10,654 $225,000
Q4 2017

Feb 09, 2018
BUY
$17.39 - $31.12 $29,876 - $53,464
1,718 Added 18.07%
11,227 $216,000
Q3 2017

Nov 09, 2017
BUY
$15.16 - $25.75 $144,156 - $244,856
9,509
9,509 $236,000

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $775M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email